Digital Therapeutics Market Projected to Reach $35.37 Billion by 2031
The Digital Therapeutics (DTx) market is forecast to grow from $10.95 billion in 2026 to $35.37 billion by 2031, driven by a compound annual growth rate (CAGR) of 26.4%.
The market for digital therapeutics (DTx) is projected to reach $35.37 billion by 2031, according to MarketsandMarkets™. The market was valued at $10.95 billion in 2026.
This growth reflects the increasing adoption of digital solutions in healthcare. DTx interventions, delivered via software and digital devices, provide evidence-based therapeutic measures for disease prevention, management, and treatment.
The analysis covers various market segments, including therapeutic areas, device technology, and end-user applications. Significant potential is identified, particularly in managing chronic diseases and mental health conditions.
With a projected CAGR of 26.4% during the forecast period, the market expansion is attributed to technological advancements, increased investment, and the healthcare industry's demand for more accessible and efficient treatment modalities.